Medicus Pharma Ltd. Common Stock
MDCXStock
$0.41−88.27%52W
Market Cap$19.74M
P/E—
Div yield—
Beta1.53
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-87.27%
Price vs S&P 500 (4W)3.43%
VGM Score15.68
Market Capitalization$19.74M
Earnings Surprise History
Q1 26-0.31est. -0.20
Analyst Recommendations
Mar 2026
Apr 2026
May 2026
Jun 2026
4.11
4.11
4.10
4.11
Industry Peers — Pharmaceuticals(563)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
MDCXMedicus Pharma Ltd. Common Stock | — | — | F | $0.41 |
| LLYEli Lilly & Co. | D | B | B | $1169.17 |
| JNJJohnson & Johnson | D | C | B | $249.97 |
| ABBVABBVIE INC. | D | C | B | $254.39 |
| MRKMerck & Co., Inc. | C | C | B | $127.63 |
| NVSNovartis AG | C | C | C | $152.73 |
| NVONovo-Nordisk A/S | C | B | C | $51.48 |
| AZNAstraZeneca PLC | C | B | C | $169.29 |
| ABTAbbott Laboratories | C | C | D | $98.83 |
| PFEPfizer Inc. | B | C | C | $25.14 |
| VRTXVertex Pharmaceuticals Inc | D | C | C | $486.03 |
About
Medicus Pharma Ltd is a clinical-stage holding company that invests in and supports life sciences and biotechnology companies developing novel treatments. The company focuses on advancing therapies through FDA-regulated clinical development to address unmet patient needs and improve therapeutic outcomes.